Metabolic reprogramming of natural killer cells in obesity limits antitumor responses

  • Xavier Michelet
  • , Lydia Dyck
  • , Andrew Hogan
  • , Roisin M. Loftus
  • , Danielle Duquette
  • , Kevin Wei
  • , Semir Beyaz
  • , Ali Tavakkoli
  • , Cathriona Foley
  • , Raymond Donnelly
  • , Cliona O’Farrelly
  • , Mathilde Raverdeau
  • , Ashley Vernon
  • , William Pettee
  • , Donal O’Shea
  • , Barbara S. Nikolajczyk
  • , Kingston H.G. Mills
  • , Michael B. Brenner
  • , David Finlay
  • , Lydia Lynch

Research output: Contribution to journalArticlepeer-review

518 Scopus citations

Abstract

Up to 49% of certain types of cancer are attributed to obesity, and potential mechanisms include overproduction of hormones, adipokines, and insulin. Cytotoxic immune cells, including natural killer (NK) cells and CD8 + T cells, are important in tumor surveillance, but little is known about the impact of obesity on immunosurveillance. Here, we show that obesity induces robust peroxisome proliferator-activated receptor (PPAR)-driven lipid accumulation in NK cells, causing complete ‘paralysis’ of their cellular metabolism and trafficking. Fatty acid administration, and PPARα and PPARδ (PPARα/δ) agonists, mimicked obesity and inhibited mechanistic target of rapamycin (mTOR)-mediated glycolysis. This prevented trafficking of the cytotoxic machinery to the NK cell–tumor synapse. Inhibiting PPARα/δ or blocking the transport of lipids into mitochondria reversed NK cell metabolic paralysis and restored cytotoxicity. In vivo, NK cells had blunted antitumor responses and failed to reduce tumor growth in obesity. Our results demonstrate that the lipotoxic obese environment impairs immunosurveillance and suggest that metabolic reprogramming of NK cells may improve cancer outcomes in obesity.

Original languageEnglish
Pages (from-to)1330-1340
Number of pages11
JournalNature Immunology
Volume19
Issue number12
DOIs
StatePublished - Dec 1 2018

Bibliographical note

Publisher Copyright:
© 2018, The Author(s), under exclusive licence to Springer Nature America, Inc.

Funding

We thank M. Wilk and J. Barrett for assistance with experiments. This research was supported by National Institutes of Health (NIH) grant R01 AI11304603 (M.B.B.), European Research Council (ERC) Starting Grant 679173, a Cancer Research Institute CLIP grant and 16/FRL/3865 (L.L.).

FundersFunder number
Cancer Research Institute CLIP16/FRL/3865
National Institutes of Health (NIH)R01 AI11304603
National Institutes of Health (NIH)
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious DiseasesR01AI134861
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
H2020 European Research Council679173
H2020 European Research Council

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology

    Fingerprint

    Dive into the research topics of 'Metabolic reprogramming of natural killer cells in obesity limits antitumor responses'. Together they form a unique fingerprint.

    Cite this